[131I] ICF01012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [131I] ICF01012, covering 2025-02-13 to 2025-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012 [EARLY_Phase 1]